Skip to main content
SpringerLink
Log in

Non-Disseminated Breast Cancer

Controversial Issues in Management

  • Book
  • © 1993

Overview

Editors:
  1. Gilbert H. Fletcher

    1. Department of Radiotherapy, M.D. Anderson Cancer Center, Houston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Seymour H. Levitt

    1. Department of Therapeutic Radiology - Radiation Oncology, University of Minnesota, Minneapolis, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Medical Radiology (MEDRAD)

Part of the book sub series: Radiation Oncology (Med Radiol Radiat Oncol)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Front Matter

    Pages I-XIV
    Download chapter PDF

  2. Is Breast Cancer Curable?

    • Gilbert H. Fletcher
    Pages 1-3

  3. Criteria of Operability in Advanced Breast Cancer

    • Walter Lawrence Jr., Gilbert H. Fletcher
    Pages 5-9

  4. Postoperative Radiotherapy and the Pattern of Distant Spread in Breast Cancer

    • Maurice Tubiana
    Pages 11-26

  5. How Much of the Axilla Should Be Dissected?

    • Robert T. Osteen
    Pages 27-34

  6. How Much of the Effect of Chemotherapy Is Due to Hormonal Manipulation?

    • Nigel P. M. Sacks, Roger P. A’Hern, Michael Baum
    Pages 35-42

  7. Chemotherapy for Node-Negative Breast Cancer

    • Richard J. Epstein, I. Craig Henderson
    Pages 43-56

  8. Treatment of the Peripheral Lymphatics: Rationale, Indications, and Techniques

    • Eric A. Strom, Marsha D. McNeese, Gilbert H. Fletcher
    Pages 57-72

  9. What Is the Value of Clinical Trials?

    • Seymour H. Levitt, Lars-Erik Rutqvist
    Pages 73-81

  10. What Have We Learned from the Stockholm Trials on Adjuvant Radiation Therapy in Early-Stage Breast Cancer?

    • Lars-Erik Rutqvist
    Pages 83-92

  11. Pathologic Factors Predictive of Local Recurrence in Patients with Invasive Breast Cancer Treated by Conservative Surgery and Radiation Therapy

    • Stuart J. Schnitt
    Pages 93-104

  12. What Is the Optimal Technique of Irradiation in Breast-Conserving Treatment?

    • Tatiana I. Lingos, Jay R. Harris
    Pages 105-115

  13. Which Patients Should Be Treated by Breast Conservation Surgery and Which by Modified Radical Mastectomy

    • Timothy J. Eberlein, Linda M. Douville
    Pages 117-128

  14. What Is the Role of Adjuvant Chemotherapy in Postmenopausal Women with Operable Breast Cancer?

    • James N. Ingle
    Pages 129-142

  15. How Should We Treat Ductal Carcinoma In Situ?

    • Abram Recht
    Pages 143-154

  16. How Successful Is Breast Reconstruction?

    • Robert M. Goldwyn
    Pages 155-160

  17. Back Matter

    Pages 161-168
    Download chapter PDF
Back to top

Keywords

About this book

In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993). Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992). These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening. These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease. What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment? What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy? Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure? When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment? This book by Levitt and Fletcher addresses these critical and important issues.

Editors and Affiliations

  • Department of Radiotherapy, M.D. Anderson Cancer Center, Houston, USA

    Gilbert H. Fletcher

  • Department of Therapeutic Radiology - Radiation Oncology, University of Minnesota, Minneapolis, USA

    Seymour H. Levitt

Bibliographic Information

  • Book Title: Non-Disseminated Breast Cancer

  • Book Subtitle: Controversial Issues in Management

  • Editors: Gilbert H. Fletcher, Seymour H. Levitt

  • Series Title: Medical Radiology

  • DOI: https://doi.org/10.1007/978-3-642-84593-2

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1993

  • Softcover ISBN: 978-3-642-84595-6Published: 12 February 2012

  • eBook ISBN: 978-3-642-84593-2Published: 06 December 2012

  • Series ISSN: 0942-5373

  • Series E-ISSN: 2197-4187

  • Edition Number: 1

  • Number of Pages: XIV, 168

  • Number of Illustrations: 5 b/w illustrations

  • Topics: Radiotherapy

Publish with us

Policies and ethics

Back to top

Search

Navigation